123 related articles for article (PubMed ID: 37598728)
1. Disruption of Ebola NP
Wu C; Wagner ND; Moyle AB; Feng A; Sharma N; Stubbs SH; Donahue C; Davey RA; Gross ML; Leung DW; Amarasinghe GK
J Mol Biol; 2023 Oct; 435(20):168241. PubMed ID: 37598728
[TBL] [Abstract][Full Text] [Related]
2. Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.
Miyake T; Farley CM; Neubauer BE; Beddow TP; Hoenen T; Engel DA
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493824
[TBL] [Abstract][Full Text] [Related]
3. Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization.
Bodmer BS; Vallbracht M; Ushakov DS; Wendt L; Chlanda P; Hoenen T
Emerg Microbes Infect; 2023 Dec; 12(2):2223727. PubMed ID: 37306660
[TBL] [Abstract][Full Text] [Related]
4. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
5. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus VP35 has novel NTPase and helicase-like activities.
Shu T; Gan T; Bai P; Wang X; Qian Q; Zhou H; Cheng Q; Qiu Y; Yin L; Zhong J; Zhou X
Nucleic Acids Res; 2019 Jun; 47(11):5837-5851. PubMed ID: 31066445
[TBL] [Abstract][Full Text] [Related]
7. The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.
Noda T; Kolesnikova L; Becker S; Kawaoka Y
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S878-83. PubMed ID: 21987764
[TBL] [Abstract][Full Text] [Related]
8. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
9. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
10. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
11. Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association.
Zhu L; Gao T; Huang Y; Jin J; Wang D; Zhang L; Jin Y; Li P; Hu Y; Wu Y; Liu H; Dong Q; Wang G; Zheng T; Song C; Bai Y; Zhang X; Liu Y; Yang W; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Xiao G; Liu X; Cao C
Nat Commun; 2022 Apr; 13(1):2256. PubMed ID: 35474062
[TBL] [Abstract][Full Text] [Related]
12. Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.
Groen J; van den Hoogen BG; Burghoorn-Maas CP; Fooks AR; Burton J; Clegg CJ; Zeller H; Osterhaus AD
Microbes Infect; 2003 Apr; 5(5):379-85. PubMed ID: 12737993
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity.
Zhu L; Jin J; Wang T; Hu Y; Liu H; Gao T; Dong Q; Jin Y; Li P; Liu Z; Huang Y; Liu X; Cao C
Elife; 2024 Jan; 12():. PubMed ID: 38285487
[TBL] [Abstract][Full Text] [Related]
14. An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions.
Leung DW; Borek D; Luthra P; Binning JM; Anantpadma M; Liu G; Harvey IB; Su Z; Endlich-Frazier A; Pan J; Shabman RS; Chiu W; Davey RA; Otwinowski Z; Basler CF; Amarasinghe GK
Cell Rep; 2015 Apr; 11(3):376-89. PubMed ID: 25865894
[TBL] [Abstract][Full Text] [Related]
15. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.
Luthra P; Ramanan P; Mire CE; Weisend C; Tsuda Y; Yen B; Liu G; Leung DW; Geisbert TW; Ebihara H; Amarasinghe GK; Basler CF
Cell Host Microbe; 2013 Jul; 14(1):74-84. PubMed ID: 23870315
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus VP35 blocks stress granule assembly.
Le Sage V; Cinti A; McCarthy S; Amorim R; Rao S; Daino GL; Tramontano E; Branch DR; Mouland AJ
Virology; 2017 Feb; 502():73-83. PubMed ID: 28013103
[TBL] [Abstract][Full Text] [Related]
17. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination of Ebola virus VP35 at lysine 309 regulates viral transcription and assembly.
van Tol S; Kalveram B; Ilinykh PA; Ronk A; Huang K; Aguilera-Aguirre L; Bharaj P; Hage A; Atkins C; Giraldo MI; Wakamiya M; Gonzalez-Orozco M; Warren AN; Bukreyev A; Freiberg AN; Rajsbaum R
PLoS Pathog; 2022 May; 18(5):e1010532. PubMed ID: 35533195
[TBL] [Abstract][Full Text] [Related]
19. The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression.
Wendt L; Brandt J; Bodmer BS; Reiche S; Schmidt ML; Traeger S; Hoenen T
Cells; 2020 Jan; 9(1):. PubMed ID: 31940815
[TBL] [Abstract][Full Text] [Related]
20. Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain.
Kasajima N; Matsuno K; Miyamoto H; Kajihara M; Igarashi M; Takada A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
